<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36676046</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>29</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Persistence of Symptoms 15 Months since COVID-19 Diagnosis: Prevalence, Risk Factors and Residual Work Ability.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">97</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life13010097</ELocationID><Abstract><AbstractText><b>Background:</b> A proportion of patients' ailments may last after recovering from acute COVID-19, with episodic and systemic symptoms of unclear etiology potentially involving different organs. <b>Study aim:</b> The aim of this study was to investigate the persistence of symptoms 15 months since COVID-19 diagnosis in patients referring to the post-COVID-19 clinic in Trieste (north-eastern Italy). <b>Methods:</b> Two-hundred-forty-seven patients were medically examined between 8 December 2020-6 April 2021, after a median time of 49 days since first positive swab test for SARS-CoV-2. After a median time of 15 months since COVID-19 diagnosis, the same patients were contacted over the phone and investigated by standardized questionnaire collecting information on any persisting symptoms and work ability index (WAI). Four multivariable logistic regression models were fitted to investigate factors associated with persistence of any respiratory, neurological, dysautonomic, or psychiatric symptoms at first (median time 49 days since COVID-19 diagnosis) as well as second (median 15 months since COVID-19 diagnosis) follow up. A multiple linear regression was also employed to investigate factors associated with higher mean WAI, assessed only at second follow up. Additionally, factors associated with persistence of symptoms 200+ days since COVID-19 diagnosis between first and second follow-up were investigated by multivariable Generalized Estimating Equation (GEE). <b>Results:</b> At first follow up (median time of 49 days since COVID-19 diagnosis) symptoms more frequently reported were fatigue (80.2%), shortness of breath (69.6%), concentration deficit (44.9%), headache (44.9%), myalgia (44.1%), arthralgia (43.3%), and anosmia (42.1%). At second follow-up (median time of 15 months since COVID-19 diagnosis) 75% patients returned to their baseline status preceding COVID-19. At first follow up males were less likely to experience neurological (OR = 0.16; 95% CI: 0.08; 0.35) as well as psychiatric (OR = 0.43; 95% CI: 0.23; 0.80) symptoms as compared to females. At first follow up, the risk of neurological symptoms increased also linearly with age (OR = 1.04; 95% CI: 1.01; 1.08) and pre-existing depression was a major risk factor for persisting dysautonomic (aOR = 6.35; 95% CI: 2.01; 20.11) as well as psychiatric symptoms (omitted estimate). Consistently, at second follow up only females experience psychiatric symptoms, whereas males exhibited significantly higher mean WAI (RC = 0.50; 95% CI: 0.11; 0.88). Additionally, neurological symptoms at second follow up were more likely in patients with pre-existing comorbidities (OR = 4.31; 95% CI: 1.27; 14.7). Finally, persistence of symptoms lasting 200+ days since COVID-19 diagnosis increased linearly with age (OR = 1.03; 95% CI 1.01-1.05) and were more likely in patients affected by pre-existing depression (OR = 2.68; 95% CI 1.60; 4.49). <b>Conclusions:</b> Following a median time of 15 months since first positive swab test, 75% patients with symptoms returned to their baseline health status preceding COVID-19. Females had a significantly lower WAI and were more likely to experience psychiatric symptoms at second follow up (15 months since COVID-19 diagnosis). Furthermore, the risk of symptoms persisting 200+ days since COVID-19 diagnosis increased with history of depression, endorsing the hypothesis that long-COVID-19 symptoms may be at least partially explained by pre-existing psychological conditions. Patient rehabilitation and psychological support may therefore play a key role in caring patients with the so called long COVID-19 syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sansone</LastName><ForeName>Donatella</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tassinari</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentinotti</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Public Health Department, University Health Agency Giuliano-Isontina (ASUGI), 34128 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontogiannis</LastName><ForeName>Dimitra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Infectious Diseases Unit, Tor Vergata University Hospital, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronchese</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Centonze</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit for Research on Innovation and Quality of Care, University Health Agency Giuliano-Isontina (ASUGI), 34128 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maggiore</LastName><ForeName>Adele</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Department, University Health Agency Giuliano-Isontina (ASUGI), 34128 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cegolon</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6285-7355</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Department, University Health Agency Giuliano-Isontina (ASUGI), 34128 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filon</LastName><ForeName>Francesca Larese</ForeName><Initials>FL</Initials><Identifier Source="ORCID">0000-0002-7717-0417</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">follow up</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword><Keyword MajorTopicYN="N">workers</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36676046</ArticleId><ArticleId IdType="pmc">PMC9862952</ArticleId><ArticleId IdType="doi">10.3390/life13010097</ArticleId><ArticleId IdType="pii">life13010097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maury A., Lyoubi A., Peiffer-Smadja N., de Broucker T., Meppiel E. Neurological Manifestations Associated with SARS-CoV-2 and Other Coronaviruses: A Narrative Review for Clinicians. Rev. Neurol. 2021;177:51&#x2013;64. doi: 10.1016/j.neurol.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Taylor S. NICE guide line on long COVID. BMJ. 2020;371:m4938. doi: 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami Z., Mastrangelo G. A Prospective Study on Risk Factors for Acute Kidney Injury and All-Cause Mortality in Hospitalized COVID-19 Patients from Tehran. Iran Front. Immunol. 2022;13:874426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9345117</ArticleId><ArticleId IdType="pubmed">35928822</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Niranthararkhumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control  Clinical Characteristics of COVID-19.  [(accessed on 4 October 2022)].  Available online:  https://www.ecdc.europa.eu/en/covid-19/latest-evidence/clinical.</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Group for the GAC-19 P-ACS. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Di Cristianziano V., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh I.M., Saddik B., Ramakrishan R., AlSwaidan N., AlAnazi A., Alhazmi D., Aloufi A., AlSumait F., Berbari E.F., Halwani R. Long term predictors of breathlessness, exercise intolerance, chronic fatigue and well-being in hospitalized patients with COVID-19: A cohort study with 4 months median follow-up. J. Infect. Public Health. 2022;15:21&#x2013;28. doi: 10.1016/j.jiph.2021.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.11.016</ArticleId><ArticleId IdType="pmc">PMC8600938</ArticleId><ArticleId IdType="pubmed">34861604</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoyo-Mora M., Villase&#xf1;or-Mora C., Cardona-Torres L.M., Mart&#xed;nez-Nolasco J.J., Barranco-Guti&#xe9;rrez A.I., Padilla-Medina J.A., Bravo-S&#xe1;nchez M.G. COVID-19 Long-Term Effects: Is There an Impact on the Simple Reaction Time and Alternative-Forced Choice on Recovered Patients? Brain Sci. 2022;12:1258. doi: 10.3390/brainsci12091258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12091258</ArticleId><ArticleId IdType="pmc">PMC9496861</ArticleId><ArticleId IdType="pubmed">36138994</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. 2021.  [(accessed on 3 October 2022)].  Available online:  https://apps.who.int/iris/handle/10665/345824.</Citation></Reference><Reference><Citation>World Health Organization  Coronavirus Disease (COVID-19): Post COVID-19 Condition. 2021.  [(accessed on 9 October 2022)].  Available online:  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>NICE  Covid-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 9 October 2022)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;16:jiac136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S., Benatti S.V., Casati M., Binda F., Zuglian G., Imeri G., Conti C., Biffi A.M., Spada M.S., Bondi E., et al. Surviving COVID-19 in Bergamo province: A post-acute outpatient re-evaluation. Epidemiol. Infect. 2021;149:e32. doi: 10.1017/S0950268821000145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., Riley S., Darzi A., Cooke G., Ward H., Elliott P. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik S., Haldar S.N., Soneja M., Mundadan N.G., Garg P., Mittal A., Desai D., Trilangi P.K., Chakraborty S., Begam N.N., et al. Post COVID-19 sequelae: A prospective observational study from Northern India. Drug Discov. Ther. 2021;15:254&#x2013;260. doi: 10.5582/ddt.2021.01093.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01093</ArticleId><ArticleId IdType="pubmed">34719599</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., I Lone N., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0(2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0(2021)</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarraj J.P.J., Burkett A.B., Hinds S.N., Paz A.S., Assing A., Juneja S., Colpo G.D., Torres L.F., Cho S.-M., Gusdon A.M., et al. Pain and Other Neurological Symptoms Are Present at 3 Months After Hospitalization in COVID-19. Patients. Front. Pain Res. 2021;2:737961. doi: 10.3389/fpain.2021.737961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpain.2021.737961</ArticleId><ArticleId IdType="pmc">PMC8915679</ArticleId><ArticleId IdType="pubmed">35295410</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco A.L., Pacheco R.L., Bagattini &#xc2;.M., Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int. J. Clin. Pract. 2021;7:1&#x2013;16. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh I.M., Saddik B., Alswaidan N., AlAnazi A., Ramakrishnan R.K., Alhazmi D., Aloufi A., AlSumait F., Berbari E., Halwani R. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PLoS ONE. 2021;16:e0260568. doi: 10.1371/journal.pone.0260568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260568</ArticleId><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., Guo L., Liu M., Xu J., et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., Zhang H., Ren L., Guo L., Liu M., Wang Y., Cui D., Wang Y., et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study. Lancet Respir. Med. 2022;10:863&#x2013;876. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdswoth L., Jawad N. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Damanti S., Cilla M., Cilona M., Fici A., Merolla A., Pacioni G., De Lorenzo R., Martinenghi S., Vitali G., Magnaghi C., et al. Prevalence of Long COVID-19 Symptoms After Hospital Discharge in Frail and Robust Patients. Front. Med. 2022;9:834887. doi: 10.3389/fmed.2022.834887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.834887</ArticleId><ArticleId IdType="pmc">PMC9329529</ArticleId><ArticleId IdType="pubmed">35911387</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whiteson J.H., Abramoff B., Azola A., Bartels M.N., Bhavaraju-Sanka R., Chung T., Fleming T.K., Henning E., Miglis M.G., et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC) PMR. 2022;14:1270&#x2013;1291. doi: 10.1002/pmrj.12894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12894</ArticleId><ArticleId IdType="pmc">PMC9538426</ArticleId><ArticleId IdType="pubmed">36169154</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Babicki M., Kapusta G., Ka&#x142;uzi&#x144;ska-Ko&#x142;at Z., Ko&#x142;at D., Jankowski P., Mastalerz-Migas A. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study. Viruses. 2022;14:1755. doi: 10.3390/v14081755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081755</ArticleId><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="pubmed">36016376</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kessel S.A.M., Hartman T.C.O., Lucassen P.L.B.J., van Jaarsveld C.H.M. Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review. Fam. Pract. 2022;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshar Y., Gaw S.L., Flaherman V.J., Chambers B.D., Krakow D., Berghella V., Shamshirsaz A.A., Boatin A.A., Aldrovandi G., Greiner A., et al. Clinical presentation of coronavirus disease 2019 (COVID-19) in pregnant and recently pregnant people. Obstet. Gynecol. 2020;136:1117&#x2013;1125. doi: 10.1097/AOG.0000000000004178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000004178</ArticleId><ArticleId IdType="pmc">PMC7673633</ArticleId><ArticleId IdType="pubmed">33027186</ArticleId></ArticleIdList></Reference><Reference><Citation>Willyard C. Could tiny blood clots cause long COVID&#x2019;s puzzling symptoms? Nature. 2022;608:662&#x2013;664. doi: 10.1038/d41586-022-02286-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-02286-7</ArticleId><ArticleId IdType="pubmed">36002482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankar K., Gould M.K., Prescott H.C. Psychological Morbidity After COVID-19 Critical Illness. Chest. 2022 doi: 10.1016/j.chest.2022.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.09.035</ArticleId><ArticleId IdType="pmc">PMC9528063</ArticleId><ArticleId IdType="pubmed">36202259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.-C., Hsu C.K., Yen M.Y., Lee P.I., Ko W.C., Hsueh P.R. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J. Microbiol. Immunol. Infect. 2022 doi: 10.1016/j.jmii.2022.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType="pmc">PMC9576029</ArticleId><ArticleId IdType="pubmed">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Al_Rubaye H.T., Almulla A.F., Al-Hadrawi D.S., Stoyanova K., Kubera M., Al-Hakeim H.K. Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways. Int. J. Environ. Res. Public Health. 2022;19:10362. doi: 10.3390/ijerph191610362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610362</ArticleId><ArticleId IdType="pmc">PMC9408685</ArticleId><ArticleId IdType="pubmed">36011997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J. Long-COVID: Cognitive deficits (brain fog) and brain lesions in non-hospitalized patients. Presse Med. 2021;51:104090. doi: 10.1016/j.lpm.2021.104090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2021.104090</ArticleId><ArticleId IdType="pmc">PMC8552626</ArticleId><ArticleId IdType="pubmed">34718113</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A., Muller S., Ostermann O.N., Gabriel E., Abida-Islam P., M&#xfc;ller-Schiffmann A., Mariappan A., Goureau O., Gruell H., Walker A., et al. SARS-CoV-2 targets neurons of 3D human brain organoids SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 2020;39:e106230. doi: 10.15252/embj.2020106230.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Young P., Finn B.C., Bruetman J., Pellegrini D., Kremer A. The chronic asthenia syndrome: A clinical approach. Medicina. 2010;70:284&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">20529781</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher C.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Depression Fact Sheet. Updated 22 March 2018.  [(accessed on 7 October 2022)].  Available online:  http://www.who.int/mediacentre/factsheets/fs369/en/</Citation></Reference><Reference><Citation>Kendler K.S., Gardner C.O. Sex Differences in the Pathways to Major Depression: A Study of Opposite-Sex Twin Pairs. J. Psychiatry. 2014;171:426&#x2013;435. doi: 10.1176/appi.ajp.2013.13101375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2013.13101375</ArticleId><ArticleId IdType="pmc">PMC3972260</ArticleId><ArticleId IdType="pubmed">24525762</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer D.M., Raymond T.J., Davis B.N. Depression: Screening and Diagnosis. Am. Fam. Physician. 2018;98:508&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">30277728</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendler K.S., Gardner C.O., Prescott C.A. Toward a comprehensive developmental model for major depression in men. Am. J. Psychiatry. 2006;163:115&#x2013;124. doi: 10.1176/appi.ajp.163.1.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.163.1.115</ArticleId><ArticleId IdType="pubmed">16390898</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Mental Disorders Collaborators Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:1700&#x2013;1712. doi: 10.1016/S0140-6736(21)02143-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02143-7</ArticleId><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan K., Zheng Y.B., Wang Y.J., Sun Y.-K., Gong Y.-M., Huang Y.-T., Chen X., Liu X.-X., Zhong Y., Su S.-Z., et al. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: A call to action. Mol. Psychiatry. 2022;27:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9168354</ArticleId><ArticleId IdType="pubmed">35668158</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L., Ronchese F., Ricci F., Negro C., Larese Filon F. SARS-CoV-2 Infection in Health Care Workers of Trieste (North-Eastern Italy), 1 October 2020&#x2013;7 February 2022: Occupational Risk and the Impact of the Omicron Variant. Viruses. 2022;14:1663. doi: 10.3390/v14081663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081663</ArticleId><ArticleId IdType="pmc">PMC9413002</ArticleId><ArticleId IdType="pubmed">36016284</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L., Negro C., Mastrangelo G., Larese Filon F. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021&#x2013;31 May 2022. Viruses. 2022;14:2688. doi: 10.3390/v14122688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122688</ArticleId><ArticleId IdType="pmc">PMC9784665</ArticleId><ArticleId IdType="pubmed">36560692</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>